Quantitative Life Sciences
  • Home
  • Leadership
  • Product
  • News
  • Contact
Select Page
BIO, QLS, and Informa Pharma Intelligence have released a new report on clinical development success rates covering 2011-2020

BIO, QLS, and Informa Pharma Intelligence have released a new report on clinical development success rates covering 2011-2020

by Miriam Rauschert | Feb 19, 2021 | Uncategorized

The report includes comparisons of success rates across indications and modalities, regulatory factors, and predictive factors driving successes and failures in drug development. This new data will help shape risk profiles and valuation metrics across investment and...
Informa Pharma Intelligence and QLS Partner to Pilot Predictive Analysis Tool for Clinical Trials

Informa Pharma Intelligence and QLS Partner to Pilot Predictive Analysis Tool for Clinical Trials

by Miriam Rauschert | Dec 2, 2020 | Uncategorized

Partnership will help inform key decisions with new drug-level probability of approval scores powered by QLS and incorporated into Informa Pharma Intelligence’s Biomedtracker LONDON, Dec. 02, 2020 (GLOBE NEWSWIRE) — Informa Pharma Intelligence, the global...

Recent Posts

  • A Structured Approach to R&D Valuation and Portfolio Strategy
  • QLS Technologies Company Announcement
  • BIO, QLS, and Informa Pharma Intelligence have released a new report on clinical development success rates covering 2011-2020
  • Informa Pharma Intelligence and QLS Partner to Pilot Predictive Analysis Tool for Clinical Trials

Recent Comments

    Copyright © 2025 QLS Technologies LLC – All Rights Reserved | Privacy Policy | Terms and Conditions